Detection of Viral Particels in Urticaria Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03151902

Enrollment

Registered

2017-05-12

Start date

2017-07-02

Completion date

2024-09-30

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urticaria Chronic

Brief summary

Blood samples from urticaria patients will be analyzed for viral particles

Detailed description

After digestion with DNase to eliminate human DNA, RNA will be reversed-transcribed and amplified with random primer/ Amplification products will be pooled and sequenced/ After substruction of sequences of vertebrates and highly repetitive sequences, contiguous sequences will be assembled and compared with motifs represented in databases of viruses. which will enable identification of putative protein sequences consistent with viruses

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with chronic spontaneous urticaria

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame	Description
viral particles	6 months	presence of viral particels

Countries

Israel

Outcome results